Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial.

Porco, Travis C; Hart, JohnORCID logo; Arzika, Ahmed M; Weaver, Jerusha; Kalua, Khumbo; Mrango, Zakayo; Cotter, Sun Y; Stoller, Nicole E; O'Brien, Kieran S; Fry, Dionna M; +7 more...Vanderschelden, Benjamin; Oldenburg, Catherine E; West, Sheila K; Bailey, Robin LORCID logo; Keenan, Jeremy D; Lietman, Thomas M; and Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Rési (2019) Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68 (12). pp. 2114-2116. ISSN 1058-4838 DOI: 10.1093/cid/ciy973
Copy

In a large community-randomized trial, biannual azithromycin distributions significantly reduced postneonatal childhood mortality in sub-Saharan African sites. Here, we present a prespecified secondary analysis showing that much of the protective effect was in the first 3 months postdistribution. Distributing more frequently than biannually could be considered if logistically feasible. Clinical Trials Registration. NCT02047981.


picture_as_pdf
Mass Oral Azithromycin for Childhood Mortality Timing of Death After Distribution in the MORDOR Trial.pdf
subject
Published Version
Available under Creative Commons: Attribution 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads